Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | LDHB | P07195 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.31 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL129220 | 1.00 | CRBN (0.36) | CRBNLMNABLMPMP22ALOX15 | |
| Methacrylic Acid SCHEMBL30127634 | 0.89 | TDP1 (0.37) | CRBN | |
| SCHEMBL2297127 | 0.82 | CRBN (0.38) | CRBNLMNABLMPMP22ALOX15 | |
| SCHEMBL24548415 | 0.82 | CRBN (0.38) | CRBNLMNABLMPMP22ALOX15 | |
| SCHEMBL9440074 | 0.79 | NFKB1 (0.38) | PTGS1AKR1C3NFKB1CA2 | |
| SCHEMBL1324470 | 0.79 | NFKB1 (0.38) | PTGS1AKR1C3NFKB1CA2 | |
| SCHEMBL2127293 | 0.79 | PTGS1 (0.34) | PTGS1AKR1C3TSHRNFKB1 | |
| SCHEMBL24548438 | 0.78 | TDP1 (0.38) | CRBNLMNABLMPMP22ALOX15 | |
| SCHEMBL19157417 | 0.76 | CRBN (0.33) | CRBNLMNABLMPMP22ALOX15 | |
| SCHEMBL27927208 | 0.76 | ALDH1A1 (0.37) | CRBNLMNABLMPMP22ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3752545-B1 | URETHANE ACRYLIC HYBRID POLYMER DISPERSION WITH ROBUST DRY/WET ADHESION AND BASECOATS PREPARED THEREFROM | SWIMC LLC (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4706111-A1 | PREPARATION OF A CATHODE PRIMING COAT | COATEX (FR) | 2026-03-11 | — | — | EP | claimed |
| EP-4706112-A1 | COMPOSITION FOR THE PREPARATION OF A CATHODE PRIMING COAT | Coatex (FR) | 2026-03-11 | — | — | EP | claimed |
| EP-3954837-B1 | CASTING IN THE SHAPE OF A SINK | SCHOCK GMBH (DE) | 2026-01-28 | — | — | EP | claimed |
| WO-2025128409-A1 | POLYVINYL ALCOHOL ACRYLATE DISPERSION COPOLYMER | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2025-06-19 | — | — | WO | claimed |
| US-20250197646-A1 | POLYVINYL ALCOHOL ACRYLATE DISPERSION COPOLYMER | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2025-06-19 | — | — | US | claimed |
| WO-2025083342-A1 | COMPOSITION OF A PRIMARY CATHODE LAYER | COATEX (FR) | 2025-04-24 | — | — | WO | claimed |
| US-20240384087-A1 | HEAT-CURABLE BIO-BASED CASTING COMPOSITION, MOLDING PRODUCED THEREFROM AND METHOD FOR PRODUCING SUCH A MOLDING | SCHOCK GMBH (DE) | 2024-11-21 | — | — | US | claimed |
| WO-2024227981-A1 | COMPOSITION FOR THE PREPARATION OF A CATHODE PRIMING COAT | COATEX (FR) | 2024-11-07 | — | — | WO | claimed |
| WO-2024227980-A1 | PREPARATION OF A CATHODE PRIMING COAT | COATEX (FR) | 2024-11-07 | — | — | WO | claimed |
| EP-1513901-B1 | LOW-VOC AQUEOUS COATING COMPOSITIONS WITH EXCELLENT FREEZE-THAW STABILITY | BASF CORP (US) | 2006-10-11 | — | — | EP | claimed |
| EP-1567115-B1 | COMPOSITIONS COMPRISING AT LEAST ONE COPOLYMER (A) AND AT LEAST ONE COPOLYMER (B), AND USE THEREOF IN COSMETIC PREPARATIONS | BASF AG (DE) | 2006-09-13 | — | — | EP | claimed |
| US-20060165638-A1 | Compositions comprising at least one copolymer (a) and at least one copolymer (b) and use thereof in cosmetic preparations | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-27 | — | — | US | claimed |
| US-20060088713-A1 | Surface modification of nanocrystals using multidentate polymer ligands | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2006-04-27 | — | — | US | claimed |
| EP-1567115-A1 | COMPOSITIONS COMPRISING AT LEAST ONE COPOLYMER (A) AND AT LEAST ONE COPOLYMER (B), AND USE THEREOF IN COSMETIC PREPARATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-31 | — | — | EP | claimed |
| US-20040245490-A1 | Top coating composition for leather | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-09 | — | — | US | claimed |
| WO-2004050043-A1 | COMPOSITIONS COMPRISING AT LEAST ONE COPOLYMER (A) AND AT LEAST ONE COPOLYMER (B), AND USE THEREOF IN COSMETIC PREPARATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-17 | — | — | WO | claimed |
| EP-1427863-A1 | LEATHER SEASONING AGENT | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-16 | — | — | EP | claimed |
| WO-2003023071-A1 | LEATHER SEASONING AGENT | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-20 | — | — | WO | claimed |
| EP-1247825-A1 | Latent cross-linkable aqueous dispersions comprising a polyurethane | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060165638-A1 | Compositions comprising at least one copolymer (a) and at least one copolymer (b) and use thereof in cosmetic preparations | CBR1, OXER1, OXGR1 | CRBN 1626/4885LMNA 2336/4885BLM 1911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.